Delivery Order SPE2DB20D2014-SPE2DB25FA91H

Award Date 1/29/25
Potential Completion Date 2/20/25
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,634.70 firm-fixed-price delivery order is for the supply of AVEED 750 MG/3 ML VIAL 3ML medical products, with a period of performance through February 27, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,213.40 firm fixed-price delivery order covers the procurement of AVEED 750 MG/3 ML vials, a specialty medication, with a period of performance through December 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $7,230.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product, with a completion date of December 11, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a Delivery Order valued at $7,707.76 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a medical product, with a performance period ending on February 14, 2025. The contract is a Firm Fixed Price arrangement, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of AVEED 750 MG/3 ML VIAL 3ML, a prescription pharmaceutical product, with a ceiling value of $7,402.50 and a completion date of September 18, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,684.92 Firm Fixed Price Delivery Order contract is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty pharmaceutical. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the Corporate Office Division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $27,954.72 firm fixed price delivery order is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a medication, to government facilities. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award, valued at $7,765.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product, with an ultimate completion date of August 2, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The order is for $15,530.40 and covers the supply of AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product. The overall IDC with Amerisourcebergen is valued at up to $999,999,999 through December 2025 for delivering a comprehensive range of medical commodities to support military treatment...
This is a federal delivery order award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,808.26 firm fixed-price contract has a completion date of February 3, 2025 and is not designated as a set-aside. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA91H
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of AVEED 750 MG/3 ML VIAL 3ML medical products. The $9,634.70 firm fixed-price delivery order has a completion date of February 20, 2025 and is not designated under any set-aside program.

The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary contracting vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/4/25, 12:58 AM